Kenya Osteoporosis Drug Market Size, Share, Price, Trends, Growth, Analysis, Outlook, Report, Forecast 2023-2028

The Kenya Osteoporosis Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Osteoporosis Drug market. This report explores all the key factors affecting the growth of the global Kenya Osteoporosis Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141646/

Report Overview

The Osteoporosis drugs market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Osteoporosis is a Bone-Mineral Density (BMD) disease in which the bones become weak and brittle due to loss of bone density which increases the risk of fractures. The World Health Organization (WHO) operationally defines osteoporosis as a Bone Mineral Density (BMD) that falls 2.5 Standard Deviations (SD) below the mean for young healthy adults. Osteoporosis is common among females above age 50 due to menopause. A positive association between osteoporosis and advancing age, poverty, illiteracy, and being underweight was found. In Kenya, the prevalence of osteoporosis stands at 24.3% among women. It is often overlooked and undertreated because it is clinically silent unless it presents with a fracture. Osteoporosis is not regarded as a health priority in Kenya.

Market Drivers

The market is majorly driven due to the rising prevalence of Osteoporosis in urban population caused due to adoption of modern lifestyles, physical inactivity, dietary changes, and hormonal changes due to ageing. Rate of urbanization in Kenya is rapidly increasing with the current rate of 4.23%.

The increase in the prevalence of Osteoporosis is also attributed to increased alcohol consumption and smoking, low levels of Vitamin D and underlying medical conditions like chronic kidney disease (CKD). Osteoporosis is males is attributed to decline in the testosterone levels with ageing.

However, the side effects caused by the drugs is one of the restraining factors. Some of the drugs have been found to have carcinogenic effect.

Diagnosis is a challenge due to low index of suspicion and due to the limited number of DEXA machines in the country and Africa as a whole. Kenya has 2 DEXA machines that serve a population of 40 million and the greater East Africa region. This limits the growth of bone diseases therapeutics market. Low levels of awareness and lack of screening contribute to restraining factors for market growth.

To Know More About COVID-19 Impact On Kenya Osteoporosis Drug Market @ https://www.prudentmarkets.com/sample-request/141646/

Market Segmentation

By Drug Class:

On the basis of drug class, the market is segmented into bisphosphonates, selective oestrogen inhibitors modulator (SERM), parathyroid hormone therapy, calcitonin, and others.

Bisphosphonates acquired the major share of osteoporosis drugs market in 2018. Bisphosphonates are commonly prescribed drugs for the treatment of osteoporosis, which boosts the growth of the market.

By Route of Administration:

By route of administration, the market is segregated into oral, injectable, and others.

The oral segment acquired the major share of the osteoporosis drugs market, owing to abundant availability of medications. Conversely, the injectable segment is expected to grow at the fastest CAGR during the forecast period, owing to factors such as rise in need for drugs, which exhibit improved bioavailability rapid mode of action.

By Gender:

On the basis of gender, the market can be segmented into males and females.

Female segment account for the largest share and is expected to witness tremendous growth throughout the forecast period.

By Distribution Channel:

On the basis of distribution channel, the market for Osteoporosis can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

The retail pharmacy segment is expected to dominate the market throughout the forecast period.

Major Players

Novartis AG and F. Hoffmann-La Roche AG are focussing on market penetration. Eli-Lilly and Company holds major shares, owing to its development of osteoporosis drugs along with its blockbuster drug Forteo. Other companies like GlaxoSmithKline, Merck & Co., Pfizer. Inc are also major contributors.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141646/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Osteoporosis Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Osteoporosis Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Osteoporosis Drug market
Chapter 2: Exclusive Summary - the basic information of the Kenya Osteoporosis Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Osteoporosis Drug
Chapter 4: Presenting the Kenya Osteoporosis Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Osteoporosis Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141646/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Osteoporosis Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.